Novozymes A/S (NVZMY)
OTC: NVZMY
· Real-Time Price · USD
61.39
-0.83 (-1.33%)
At close: Oct 15, 2025, 3:59 PM
61.51
0.20%
After-hours: Oct 15, 2025, 04:00 PM EDT
Novozymes A/S Income Statement
Financials in DKK. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 3.83B | 17.9B | 17.55B | 14.95B |
Cost of Revenue | 2.02B | 8.18B | 7.96B | 6.33B |
Gross Profit | 1.81B | 9.72B | 9.58B | 8.62B |
Operating Income | 659M | 3.98B | 4.63B | 4.01B |
Interest Income | 26.9M | 16.74M | 18M | 18M |
Pretax Income | 417.1M | 3.91B | 4.56B | 3.92B |
Net Income | 305.8M | 3.02B | 3.68B | 3.15B |
Selling & General & Admin | 765.5M | 3.32B | 3.22B | 2.79B |
Research & Development | 413.2M | 2.02B | 2B | 2.01B |
Other Expenses | -28.2M | 405M | -37.04M | -66M |
Operating Expenses | 1.15B | 5.75B | 5.03B | 4.74B |
Interest Expense | 76.4M | 23.24M | 102M | 102M |
Selling & Marketing Expenses | 550.9M | 2.37B | 2.27B | 1.94B |
Cost & Expenses | 3.17B | 13.92B | 13.13B | 11.07B |
Income Tax Expense | 111.3M | 870M | 870M | 779M |
Shares Outstanding (Basic) | 277.9M | 277.94M | 278.7M | 277.92M |
Shares Outstanding (Diluted) | 277.9M | 278.01M | 278.73M | 280.23M |
EPS (Basic) | 1.10 | 1.46 | 13.29 | 11.32 |
EPS (Diluted) | 1.10 | 1.46 | 13.19 | 11.23 |
EBITDA | 8.07B | 5.47B | 6.12B | 5.2B |
EBIT | 6.29B | 4.08B | 4.66B | 4.03B |
Depreciation & Amortization | 1.78B | 1.39B | 1.46B | 1.37B |
Source: Financial Modeling Prep. Financial Sources.